National

World Trade Report calls for multilateral trade cooperation amid pandemic shocks

Nov 17, 2021

Geneva (Switzerland), November 17: The World Trade Organization (WTO) on Tuesday published the 2021 edition of World Trade Report, calling for more multilateral and regional trade cooperation after analyzing vulnerabilities and resilience in global trading system amid pandemic.
"While the WTO already contributes to economic resilience in important ways, it can and must do more, as we confront a future of increasing natural and man-made risks and disasters," WTO Director-General Ngozi Okonjo-Iweala said in her foreword to the report titled "Economic resilience and trade."
"Today's highly connected global economy is more exposed to risks and vulnerable to shocks, from supply chain cut-offs to infectious disease outbreaks, but that it is also more resilient to shocks when they do strike," she said.
The report emphasized that multilateral and regional trade cooperation is conducive to the global response to future crises.
Noting that the ongoing health and economic crisis caused by the COVID-19 pandemic has been a massive stress test for the world trading system, the report said the system has proved itself more resilient than many expected at the outset of the crisis, and many economies have gradually begun to recover.
More trade cooperation at the multilateral or regional level, backed by strong international trade rules, can support the various domestic strategies deployed to avoid and mitigate risks and to prepare for, manage and recover from shocks, the report said.
The World Trade Report is an annual publication that aims to deepen understanding about trends in trade, trade policy issues and the multilateral trading system.
Source: Xinhua

More news

ImmunoACT announces partnership with Mango Sciences to bring the world's first bridge financing plan and value-based offering for CAR-T therapy for cancer patients in India

Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, to expand access and affordability of ImmunoACT's NexCAR19TM chimeric antigen receptor T-cell (CAR-T) for leukaemia and lymphoma . The partnership will enable patients to avail easy 0% interest EMI plans of up to 10 lakhs to cover the cost of CAR-T. Additionally, a value-based offering of up to ₹10 lakhs can also be availed by clinically eligible patients.

Dec 02, 2025